Plain-English translation of NCT06521372 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This research study is testing a new artificial intelligence tool called Magenta that analyzes images of your eggs to predict which ones are most likely to develop into healthy embryos. Normally, eggs are randomly grouped together during the early development phase of IVF, but this study compares that standard approach to using Magenta's AI analysis to sort eggs into groups based on quality. The goal is to see if this smarter sorting approach leads to more usable embryos and higher pregnancy rates.
Right now, fertility doctors have no standard way to decide which eggs should be grouped together during IVF, so eggs are sorted randomly. This tool could help identify patterns in egg quality that human eyes alone cannot see, potentially improving the chances that your eggs develop into healthy embryos ready for transfer.
You likely qualify if…
You likely don't qualify if…
If you enroll, you will undergo a standard IVF cycle as planned. You will be randomly assigned to either the control group (where your eggs are sorted randomly into groups) or the Magenta group (where the AI tool analyzes your eggs to inform how they are grouped). Your eggs and embryos will be tracked through development, and the clinic will collect your full lab results and pregnancy outcomes to compare how the two grouping methods performed. Your participation involves your regular IVF appointments and allowing the research team to use your lab data and egg images for this comparison.
AI-generated summary from trial data · Aug 20, 2026 · Not medical advice
United States